Vontobel Holding’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,787
Closed -$608K 1033
2022
Q2
$608K Sell
5,787
-2,193
-27% -$280K 0.01% 661
2022
Q1
$1.38M Sell
7,980
-3,766
-32% -$563K 0.01% 531
2021
Q4
$1.93M Sell
11,746
-3,238
-22% -$520K 0.02% 445
2021
Q3
$2.23M Buy
14,984
+12,625
+535% +$2.62M 0.02% 423
2021
Q2
$578K Sell
2,359
-289
-11% -$75.8K 0.01% 725
2021
Q1
$701K Buy
2,648
+15
+0.6% +$4.23K 0.01% 593
2020
Q4
$772K Buy
+2,633
New +$675K 0.01% 572

Other funds holding AMED

Vontobel Holding's AMED Position: Q3 2022 in Review

Vontobel Holding sold out of Amedisys (AMED) in Q3 2022, closing a stake of 5,787 shares — an estimated $608K sold.

Vontobel Holding first reported a position in AMED in Q4 2020 and held it in 7 quarters. The position peaked at $2.23M in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Vontobel Holding reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Vontobel Holding sold 5,787 Amedisys shares in Q3 2022, an estimated $608K.
  • Vontobel Holding first reported a position in Amedisys in Q4 2020 and held it in 7 quarters.
  • Vontobel Holding's Amedisys position peaked at $2.23M in Q3 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Vontobel Holding's 13F filing for Q3 2022, filed 4 Nov 2022.